Actively Recruiting
Pencil Beam Scanning in Patients With Renal Tumors
Led by Children's Hospital of Philadelphia · Updated on 2026-04-15
28
Participants Needed
1
Research Sites
565 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a pilot study to assess acute toxicity in patients receiving flank irradiation using proton therapy for renal tumors.
CONDITIONS
Official Title
Pencil Beam Scanning in Patients With Renal Tumors
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Less than 30 years of age
- Diagnosis of Wilms tumor or clear cell sarcoma of the kidney requiring radiation therapy as standard care
- Patients with favorable histology, stage III Wilms tumor
- Patients with focal or diffuse anaplasia
- Patients with clear cell sarcoma of the kidney
- Candidate for external beam radiotherapy based on standard care for Wilms tumor or CCSK
You will not qualify if you...
- Prior radiotherapy to the area of the kidney tumor
- Chemotherapy given for Wilms tumor or clear cell sarcoma of the kidney
- Currently pregnant or breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104
Actively Recruiting
Research Team
C
Christine Hill-Kayser, MD
CONTACT
R
Ratnakar Patti
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here